Samsara BioCapital, LLC

Q2 2026 13F-HR Holdings

Location
Palo Alto, CA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
24
Total value ($000)
$1,217,462
Net value change ($000)
+188,359 (18.3%)
New positions
4
Sold out positions
2
Turnover %
9.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ALAMAR BIOSCIENCES INC 67,192 NEW
SRRK 40,282 11.9%
ALMS 38,769 27.7%
SEPN 29,790 39.4%
NGNE 19,387 56.0%
PARABILIS MEDICINES INC 15,219 NEW
ARTV 9,262 NEW
STRO 8,811 33.3%
ELOXX PHARMACEUTICALS INC 5,552 NEW
JBIO 2,747 20.2%
Top Reduces (Value $000, Stocks/ETFs)
KLRS -22,284 -29.8%
SGP -7,701 -14.1%
ACLX -6,989 -100.0%
IVA -4,961 -17.2%
PVLA -4,791 -100.0%
UPB -4,176 -63.0%
GOSS -1,184 -49.9%
XFOR -1,051 -13.9%
CHRS -994 -17.2%
MLYS -646 -0.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type